The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension

Journal of Hypertension

Volumn 16, Issue 11, 1998, Pages 1685-1691

  Parati, Gianfranco ^a,b,e   Omboni, Stefano ^a   Rizzoni, Damiano ^d   Agabiti Rosei, Enrico ^d   Mancia, Giuseppe ^a,b,c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e Istituto Scientific Auxologica   (Italy)

Author keywords

Antihypertensive treatment; Blood pressure variability; End organ damage; Hypertension; Trough:peak ratio

Indexed keywords

HYDROCHLOROTHIAZIDE; LISINOPRIL;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0031792684     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816110-00016     Document Type: Article

References (24)

1. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
2. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
3. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M. Clinical relevance of night-time blood pressure and of day-time blood pressure variability. Arch Intern Med 1992; 152:1855-1860.
4. Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension 1993; 21:510-522.
5. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens 1995; 13 (suppl 4):S27-S34.
6. Lipicky RJ, Trough/peak ratio: the rationale behind the United States Food and Drug Administration recommendations. J Hypertens 1994; 12 (suppl 8):S17-S19.
7. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough-to-peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995; 13:1105-1112.
8. Omboni S, Fogari R, Palatini P, Rappelli A, Mancia G, on behalf of the SAMPLE Study Group. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the SAMPLE Study. Hypertension 1998; 32:52-58.
9. Bieniaszewski L, Staessen JA, Byttebier G, De Leeuw P, van Hedent T, Fagard R. Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. Blood Press 1995; 4:350-357.
10. Rizzoni D, Castellano M, Muiesan ML, Porteri E, Agabiti-Rosei E. Beyond trough:peak ratio: a new index of the smoothness of the antihypertensive effect of a drug. High Blood Press 1997; 6:110-115.
11. Mancia G, Zanchetti A, Agabiti Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of regression of ventricular hypertrophy. Circulation 1997; 95:1464-1470.
12. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of non-invasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24 h intra-arterial blood pressure. Hypertension 1992; 20:227-232.
13. Sahn DY, De Maria A, Kinlo J, Weyman A, the Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55:613-618.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986; i:307-310.
16. Norusis MJ. SPSS/PC+ v2.0 base manual. Cary, NC: SPSS; 1990.
17. Trazzi S, Mutti E, Frattola A, Imholz BPM, Parati G, Mancia G. Reproducibility of non invasive and intra-artetial blood pressure monitoring: implications for studies on anti-hypertensive treatment. J Hypertens 1991; 9:115-119.
18. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens 1989; 7 (suppl 3):S29-S32.
19. Casale PN, Devereux RB, Milner M. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
20. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
21. Agabiti-Rosei E, Muiesan ML. Reversal of cardiovascular structural changes during long-term antihypertensive therapy. J Hum Hypertens 1991; 5 (suppl 1):41-47.
22. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato S, Agabiti-Rosei E. Association of changes in left ventricular mass with prognosis during long-term anti-hypertensive treatment. J Hypertens 1995; 13:1091-1096.
23. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 1983; 5:264-269.
24. Imholz BPM, Langewouters GJ, van Montfrans GA, Parati G, van Goudoever J, Wesseling KH, et al. Feasibility of ambulatory, continuous 24 hour finger arterial pressure recording. Hypertension 1993; 21:65-73.